Clients with Renal Impairment Ritalin has not been examined in renally-impaired patients. Renal impairment is expected to get nominal effect on the pharmacokinetics of methylphenidate since fewer than one% of a radiolabeled dose is excreted in the urine as unchanged compound, and the foremost metabolite (ritalinic acid), has little if any pharmacol